News Merck looking to rare disease deals to build health momentum Germany's Merck KGaA is looking at making further acquisitions to boost its business, with a focus on life sciences and rare diseases.
News J&J streamlines with plan to hive off orthopaedics unit Johnson & Johnson has said it wants to spin off its orthopaedics division as part of an effort to redirect its business towards higher-growth areas.
News Indivior stops Opvee promotion in New York after settlement Indivior has agreed to halt all marketing of its opioid overdose drug Opvee in New York after being rapped for mispromoting it to health officials.
News PhRMA unveils DTC sales site, as more drugmakers join in Pharma is embracing DTC selling of medicines in the US, and industry body PhRMA has stepped in to help cut out the middlemen in the supply chain.
News AstraZeneca hops on the DTC sales train in the US AstraZeneca has become the latest pharma group to set up a direct-to-consumer sales channel in the US, covering Farxiga, Airsupra, and FluMist.
News BMS adds discounted psoriasis drug to its DTC channel Bristol Myers Squibb expands its DTC sales in the US with the addition of psoriasis drug Sotyktu at an 80% discount for cash buyers.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.